Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Third Harmonic Bio, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
THRD
Nasdaq
2830
www.thirdharmonicbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Third Harmonic Bio, Inc.
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
- Jun 13th, 2025 4:00 am
Third Harmonic Bio Shareholders Approve Liquidation Plan
- Jun 12th, 2025 8:19 am
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
- Jun 12th, 2025 6:00 am
Here’s Why Third Harmonic Bio (THRD) Fell in Q1
- May 2nd, 2025 7:16 am
Top Premarket Gainers
- Apr 14th, 2025 6:48 am
Third Harmonic outlines plans for dissolution
- Apr 14th, 2025 5:55 am
Third Harmonic Seeks to Liquidate, Dissolve Company
- Apr 14th, 2025 5:28 am
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
- Apr 14th, 2025 4:45 am
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
- Mar 27th, 2025 6:10 am
Third Harmonic Bio, Inc. (THRD) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Mar 4th, 2025 7:35 am
Companies Like Third Harmonic Bio (NASDAQ:THRD) Are In A Position To Invest In Growth
- Feb 23rd, 2025 6:12 am
Third Harmonic Bio, Inc. (THRD) Upgraded to Buy: What Does It Mean for the Stock?
- Feb 14th, 2025 10:00 am
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. (THRD)
- Feb 14th, 2025 7:35 am
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
- Feb 12th, 2025 2:41 pm
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
- Feb 11th, 2025 5:00 am
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK
- Feb 11th, 2025 4:38 am
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
- Nov 25th, 2024 2:00 pm
Wall Street Analysts Believe Third Harmonic Bio, Inc. (THRD) Could Rally 26.67%: Here's is How to Trade
- Nov 11th, 2024 7:55 am
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
- Nov 7th, 2024 2:00 pm
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
- Nov 7th, 2024 6:10 am
Scroll